Spain: Medical Technology 165 Million Euro Investment in Facility for Pre-Filled Drug Delivery Devices
BD (Becton, Dickinson and Company), a global medical technology company, will build a € 165 million ($ 200 million) high-tech manufacturing facility in city of Zaragoza, Spain, for the production of drug delivery devices.
Madrid/Spain — Medical technology company BD plans to begin construction of a new plant for drug delivery devices in Spain in late 2021. The new facility in Zaragoza will be the fourth manufacturing plant for the company in Spain. The site will initially have a workforce of 150 people and encompass an area of 8000 m2. By 2030 it is expected to employ up to 600 people with an area of 30,000 m2. The new facility is to meet high sustainability and eco-efficiency standards, and it will be a fully digital site, incorporating the latest in intelligent and autonomous technologies, also knowns as Industry 4.0 solutions.
BD's new plant in will produce drug delivery devices, primarily for pharmaceutical companies that supply the European market with drugs in pre-fillable syringes such as vaccines and other biologic drugs. This new plant will also add needed capacity to support major vaccination campaigns, such as the one currently taking place in response to the Covid-19 pandemic.
The new site represents a portion of the $ 1.2 billion investment over four years that was announced in December 2020 to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) as part of BD’s 2025 growth strategy. The new site also continues BD’s commitment to Spain, where it started operations more than 40 years ago and currently has three production plants located in San Agustín de Guadalix, Fraga and Almaraz. These facilities produce a total of ten billion medical devices each year and employ 1500 people. The Fraga plant is a key production site for the manufacture of Covid-19 vaccination injection devices.